206 related articles for article (PubMed ID: 24903387)
1. Use of renin-angiotensin inhibitors in people with renal artery stenosis.
Evans KL; Tuttle KR; Folt DA; Dawson T; Haller ST; Brewster PS; He W; Jamerson K; Dworkin LD; Cutlip DE; Murphy TP; D'Agostino RB; Henrich W; Cooper CJ
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1199-206. PubMed ID: 24903387
[TBL] [Abstract][Full Text] [Related]
2. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
Tuttle KR; Dworkin LD; Henrich W; Greco BA; Steffes M; Tobe S; Shapiro JI; Jamerson K; Lyass A; Pencina K; Massaro JM; D'Agostino RB; Cutlip DE; Murphy TP; Cooper CJ
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1180-1188. PubMed ID: 27225988
[TBL] [Abstract][Full Text] [Related]
3. Use of renin-angiotensin system blockade in patients with renal artery stenosis.
Cohen JB; Townsend RR
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1149-52. PubMed ID: 24903389
[No Abstract] [Full Text] [Related]
4. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety and efficacy of renin-angiotensin blockade in atherosclerotic renal artery stenosis.
Sofroniadou S; Kassimatis T; Srirajaskanthan R; Reidy J; Goldsmith D
Int Urol Nephrol; 2012 Oct; 44(5):1451-9. PubMed ID: 22127407
[TBL] [Abstract][Full Text] [Related]
6. Predictors of long-term beneficial effects on blood pressure after percutaneous transluminal renal angioplasty in atherosclerotic renal artery stenosis.
Alhadad A; Mattiasson I; Ivancev K; Lindblad B; Gottsäter A
Int Angiol; 2009 Apr; 28(2):106-12. PubMed ID: 19367240
[TBL] [Abstract][Full Text] [Related]
7. Mortality and Renal Replacement Therapy after Renal Artery Stent Placement for Atherosclerotic Renovascular Disease.
Misra S; Khosla A; Allred J; Harmsen WS; Textor SC; McKusick MA
J Vasc Interv Radiol; 2016 Aug; 27(8):1215-24. PubMed ID: 27296703
[TBL] [Abstract][Full Text] [Related]
8. Stenting and medical therapy for atherosclerotic renal-artery stenosis.
Cooper CJ; Murphy TP; Cutlip DE; Jamerson K; Henrich W; Reid DM; Cohen DJ; Matsumoto AH; Steffes M; Jaff MR; Prince MR; Lewis EF; Tuttle KR; Shapiro JI; Rundback JH; Massaro JM; D'Agostino RB; Dworkin LD;
N Engl J Med; 2014 Jan; 370(1):13-22. PubMed ID: 24245566
[TBL] [Abstract][Full Text] [Related]
9. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
10. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
Li X; Liu Y; Lv J; Shi S; Liu L; Chen Y; Zhang H
Clin J Am Soc Nephrol; 2014 Mar; 9(3):484-9. PubMed ID: 24408121
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel blockers are associated with improved survival and lower cardiovascular mortality in patients with renovascular disease.
Deshmukh H; Barker E; Anbarasan T; Levin D; Bell S; Witham MD; George J
Cardiovasc Ther; 2018 Dec; 36(6):e12474. PubMed ID: 30372589
[TBL] [Abstract][Full Text] [Related]
12. Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes.
Clase CM; Barzilay J; Gao P; Smyth A; Schmieder RE; Tobe S; Teo KK; Yusuf S; Mann JF
Kidney Int; 2017 Mar; 91(3):683-690. PubMed ID: 27927602
[TBL] [Abstract][Full Text] [Related]
13. The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.
Bramlage P; Schmieder RE; Gitt AK; Baumgart P; Mahfoud F; Buhck H; Ouarrak T; Ehmen M; Potthoff SA;
Trials; 2015 Dec; 16():581. PubMed ID: 26686682
[TBL] [Abstract][Full Text] [Related]
14. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period.
Mousa AY; Campbell JE; Stone PA; Broce M; Bates MC; AbuRahma AF
J Vasc Surg; 2012 Feb; 55(2):421-7. PubMed ID: 22112553
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.
Malacco E; Omboni S; Mallion JM; Volpe M;
High Blood Press Cardiovasc Prev; 2012 Dec; 19(4):213-22. PubMed ID: 23430666
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Effects of RAAS Blockade in Ischemic Nephropathy.
Rivoli L; Di Mario F; Coppolino G; Gigante A; Barbano B; Farrah TE; Rosato E; Fuiano G; Cianci R
Curr Drug Metab; 2016; 17(6):550-8. PubMed ID: 26892730
[TBL] [Abstract][Full Text] [Related]
17. Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis.
Saad A; Herrmann SMS; Eirin A; Ferguson CM; Glockner JF; Bjarnason H; McKusick MA; Misra S; Lerman LO; Textor SC
Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28916603
[TBL] [Abstract][Full Text] [Related]
18. Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI.
Hsu CY; Liu KD; Yang J; Glidden DV; Tan TC; Pravoverov L; Zheng S; Go AS
Clin J Am Soc Nephrol; 2020 Jan; 15(1):26-34. PubMed ID: 31843974
[TBL] [Abstract][Full Text] [Related]
19. Validity of estimated glomerular filtration rates for assessment of renal function after renal artery stenting in patients with atherosclerotic renal artery stenosis.
Crimmins GM; Madder RD; Marinescu V; Safian RD
JACC Cardiovasc Interv; 2014 May; 7(5):543-9. PubMed ID: 24746646
[TBL] [Abstract][Full Text] [Related]
20. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63-month experience.
Onuigbo MA; Onuigbo NT
Ren Fail; 2008; 30(4):363-71. PubMed ID: 18569908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
